Contraceptive Pills Market - Growth, Trends, and Forecast (2020 - 2025)

The Contraceptive Pills Market is segmented by Hormone Type (Progestin Pills and Combination Pills), Category, and Geography.

Market Snapshot

Study Period:

2016-2024

Base Year:

2019

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The market is expected to register a CAGR of nearly 9%, during the forecast period, 2019 - 2024. It is segmented by hormone type, category, and geography.

  • Unwanted pregnancies are on the rise, globally. Government bodies of various countries have been taking measures, like promoting the use of contraceptive pills, in order to reduce the number of unwanted pregnancies.
  •  It is estimated that among the number of pregnancies that occur in the United States, nearly 76% are unwanted and occur in women under the age of 30.
  • According to Harvard researchers, single parenthood, due to unwanted pregnancies, is the reason for holding out on economic mobility, more than other variables, like education and race.
  • According to the data published in the Medical Journal of Australia, almost half of all the pregnancies in Australia are unplanned. As per a survey published in the Medical Journal of Australia, in 2018, among 1,390 women who reported pregnancies over the past 10 years, more than a quarter (362) said they had an unintended pregnancy, while 94 women said that their pregnancies were unwanted.
  • Given the widespread implications of unwanted pregnancies, the market for contraceptive pills is expected to experience a surge during the forecast period.

Scope of the Report

As per the scope of the report, contraceptive pill is a kind of medicine with hormones, which generally comes in a pack. Contraceptive pills are affordable and effective, and offer other health benefits. The contraceptive pill works by stopping the sperm from joining with an egg during fertilization. The hormones in the pill stop ovulation. Furthermore, these hormones thicken the mucus on the cervix, thus, blocking the sperm. 

By Hormone Type
Progestin Pills
Combination Pills
Monophasic
Triphasic
Other Combination Pills
By Category
Generic
Branded
Geography
North America
US
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Generic Segment is Expected to Hold the Largest Share of the Market

The generic segment has the largest share in the market, due to the widespread adoption of generic contraceptives, owing to their low prices and ease of use. Furthermore, the increasing need for population control and rising incidence of abortion have driven the growth of generic contraceptive pills in the market. There has been a dramatic increase in the availability of various birth control pills in the United States, as a result of implementation of the Drug Price Competition and Patent Term Restoration Act of 1984 (Hatch-Waxman Act), which set up the modern system of generic drug approval and regulation. Physicians, pharmacists, and women can choose pills based on price, as the action of these contraceptives, or their therapeutic equivalence, was essentially the same. Major manufacturers in the market are finding ways to make their products stand out from the crowd. Thus, all these initiatives are expected to propel the growth of the market during the forecast period. 

To understand key trends, Download Sample Report

North America Holds the Largest Share in the Market

North America dominates the contraceptive pills market, owing to rapid developments in the healthcare infrastructure and high awareness about contraceptive pills in the region. In 2017, there were approximately 60 million women in the United States in their child-bearing age (age: 15 - 44). Around 70% of these women were at the risk of unintended pregnancy. More than 99% of women aged between 15 - 44 years have used at least one contraceptive method. This indicates the high awareness about and demand for contraceptives, for avoiding unintended pregnancies, in the United States. Additionally, contraceptive pills account for the largest share of expenditure on contraceptive methods in the United States.

To understand geography trends, Download Sample Report.

Competitive Landscape

The competition in the market is set to intensify, as several key players in are focusing on the expansion of their product portfolios, through acquisitions and collaborations. The contraceptive pills market is expected to open up several opportunities for the new players, as well as the currently established market leaders. The key players in the market include Bayer Healthcare, Amgen Inc., Baxter, Gilead Sciences Inc., and GlaxoSmithKline PLC, among others.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Table Of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Awareness about Contraceptive Pills

      2. 4.2.2 Need to Prevent Unwanted Abortions

      3. 4.2.3 Ease of Use and Low Cost

    3. 4.3 Market Restraints

      1. 4.3.1 Side Effects Associated with the Use of Contraceptive Drugs

      2. 4.3.2 Increased Usage of Alternative Birth Control Methods

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Hormone Type

      1. 5.1.1 Progestin Pills

      2. 5.1.2 Combination Pills

        1. 5.1.2.1 Monophasic

        2. 5.1.2.2 Triphasic

        3. 5.1.2.3 Other Combination Pills

    2. 5.2 By Category

      1. 5.2.1 Generic

      2. 5.2.2 Branded

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 US

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 UK

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle East & Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle East & Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Bayer Healthcare

      2. 6.1.2 Amgen Inc.

      3. 6.1.3 Baxter

      4. 6.1.4 Gilead Sciences Inc.

      5. 6.1.5 GlaxoSmithKline PLC

      6. 6.1.6 Johnson & Johnson

      7. 6.1.7 Merck & Co. Inc.

      8. 6.1.8 Novartis AG

      9. 6.1.9 Pfizer Inc.

      10. 6.1.10 Sanofi

  7. *List Not Exhaustive
  8. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

** Subject to Availability

**Competitive Landscape Covers - Business Overview, Financials, Products, Strategies, and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Related Reports